Table 2. Multivariate regression analysis for PCSM using the proportional hazards model described by Fine and Gray, accounting for OCM as a competing risk for PCSM.
| AHR [95% CI] | p | |
| Gleason Score: | ||
| 8 | 1.000 | |
| 9 | 2.146 [1.913-2.406] | <0.001 |
| 10 | 4.402 [3.539-5.474] | <0.001 |
| Race: | ||
| AsA | 1.000 | |
| AA | 2.295 [1.708-3.083] | <0.001 |
| NHW | 1.989 [1.519-2.605] | <0.001 |
| Treatment: | ||
| EBRT+BT | 1.000 | |
| RP | 0.766 [0.630-0.931] | 0.007 |
| EBRT | 1.268 [1.059-1.517] | 0.010 |
| T stage: | ||
| T1 | 1.000 | |
| T2 | 1.234 [1.095-1.392] | 0.001 |
| T3 | 1.998 [1.682-2.373] | <0.001 |
| T4 | 3.158 [2.147-4.645] | <0.001 |
| Age at diagnosis: | 1.005 [0.998-1.013] | 0.150 |
| Year of diagnosis: | 0.913 [0.888-0.939] | <0.001 |